Skip to content

China

AstraZeneca CEO: China already a global innovation hub

Multinational pharmaceutical company AstraZeneca is bullish about China’s role as a global innovation powerhouse, underpinned by the country’s sound prospects as well as its growing innovation capability in new and emerging sectors, its top executive said. Pascal Soriot, global CEO of AstraZeneca, said in an exclusive interview with China Daily that the company is investing…

Ajlan & Bros hails policy steps as confidence boosts

Ajlan & Bros’ booth is seen during a services expo in Beijing. CHINA DAILY Ajlan & Bros Group, the largest Saudi Arabian private sector conglomerate in China, said it has been benefiting from the country’s improving business environment and further opening-up, citing a surge in new foreign investments as evidence of the market’s growing appeal.…

China’s tech advances boon for global firms

China is emerging as an innovation-centric economy, with technological advances setting the stage for global shifts, while foreign companies can leverage their expertise around the world to help Chinese businesses bolster digital transformation, said Samantha Zhu, chairperson of Accenture Greater China. “For businesses in China looking to boost their productivity and maintain competitiveness, technologies led…

Nivea Shanghai to start mass production of anti-spot product in July

NIVEA products are on display at a retail counter in Changzhou, Jiangdu province, on Oct 6, 2024. [Photo/VCG] Nivea, using its parent company Beiersdorf’s patented anti-spot ingredient Thiamidol 630, will start mass production of its new product in its Shanghai facility in July, with roll out to the market expected two months later. The announcement…

China’s medical reform fasttracks innovation: US pharma giant

BEIJING – China’s reform efforts to promote research and development on medical innovation and shorten the review and approval time for the launch of related drugs have provided innovation-driven pharmaceutical firms with greater opportunities, a senior executive with US medicine giant Eli Lilly and Company said. “Related reforms have stimulated innovation in the pharmaceutical sector,…

FedEx pledges further investment in China

FedEx employees unload cargo from an aircraft at Guangzhou Baiyun International Airport in Guangdong province in March. CHINA DAILY FedEx Corp plans to further expand its presence in China as the United States-based express transportation service provider aims to fortify supply chains and boost investment in response to China’s pivotal role in the global economy, the…

First full-link integrated test on large-scale vehicle-to-grid interaction launched in Shanghai

The nation’s first full-link integrated test on large-scale vehicle-to-grid interaction kicks off in Shanghai on March 31. [Photo provided to chinadaily.com.cn] The nation’s first full-link integrated test on large-scale vehicle-to-grid (V2G) interaction was kicked off in Shanghai on March 31, according to the State Grid Shanghai Municipal Electric Power Co. Shanghai was among the first…

US pharmaceutical giant opens R&D center in Beijing

The logo of US pharmaceutical company Pfizer at the 7th China International Import Expo in Shanghai, on Nov 7, 2024. [Photo/VCG] BEIJING – US pharmaceutical giant Pfizer’s new research and development (R&D) center officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA) on Saturday. As the company’s third R&D center in China, the…

Sinopec, CATL partner to build nationwide battery-swap stations

China Petroleum and Chemical Corp (Sinopec) and Contemporary Amperex Technology Co Ltd (CATL), a leading battery maker, have signed a framework agreement on Wednesday for industrial and capital cooperation in Beijing, planning to build no fewer than 500 battery swap stations nationwide, with the future goal of jointly constructing 10,000 such stations. The initiative aims…

Hengrui Pharma makes new breakthrough in lung cancer treatment

Chinese and international oncologists witness the release of a breakthrough finding by a Chinese pharma company during the European Lung Cancer Congress 2025, held in France between March 26 and 29. [Photo provided to chinadaily.com.cn] A key lung cancer congress held in Europe disclosed that a new breakthrough has been made by Hengrui Pharmaceuticals, a…